Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
8,738
Total Claims
$1.2M
Drug Cost
742
Beneficiaries
$1,586
Cost/Patient
Risk Score Breakdown 12/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-87%
Opioid rate vs peers
0.3% vs 2.2% avg
+12%
Cost per patient vs peers
$1,586 vs $1,411 avg
+61%
Brand preference vs peers
17.1% vs 10.6% avg
Opioid Prescribing
0.3%
Opioid Rate
25
Opioid Claims
$229
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,486 claims · $1.0M
Generic: 7,183 claims · $164K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Semaglutide | 125 | $150K |
| Empagliflozin | 107 | $147K |
| Apixaban | 89 | $111K |
| Semaglutide | 55 | $93K |
| Dulaglutide | 57 | $77K |
| Rivaroxaban | 52 | $69K |
| Tirzepatide | 25 | $39K |
| Evolocumab | 34 | $29K |
| Mirabegron | 18 | $23K |
| Fluticasone/Umeclidin/Vilanter | 26 | $23K |
| Budesonide/Formoterol Fumarate | 32 | $23K |
| Fluticasone Propionate | 15 | $15K |
| Fluticasone Propion/Salmeterol | 12 | $12K |
| Alirocumab | 18 | $12K |
| Fluticasone/Vilanterol | 16 | $11K |
Prescribing Profile
Patient Profile
74
Avg Age
63%
Female
0.86
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data